A mobile app for the treatment of female mixed and urgency incontinence: a cost-effectiveness analysis in Sweden.
Int Urogynecol J
; 33(5): 1273-1282, 2022 05.
Article
em En
| MEDLINE
| ID: mdl-35278093
ABSTRACT
INTRODUCTION AND HYPOTHESIS:
A previous randomized controlled trial (RCT) demonstrated that the app Tät II, for self-management of mixed urinary incontinence (MUI) and urgency urinary incontinence (UUI), yielded significant, clinically relevant improvements in symptom severity and quality of life (QoL) compared with a control group. We aimed to assess the cost-effectiveness of Tät II.METHODS:
A cost-utility analysis with a 1-year societal perspective was carried out, comparing Tät II with an information app. Data were collected alongside an RCT 122 community-dwelling women aged ≥18 years with MUI or UUI ≥2 times/week were randomized to 3 months of Tät II treatment focused on pelvic floor muscle training (PFMT) and bladder training (BT; n = 60), or to an information app (n = 62). Self-assessed data from validated questionnaires were collected at baseline and at 3-month and 1-year follow-ups. Costs for assessment, treatment delivery, incontinence aids, laundry, and time for PFMT and BT were included. We calculated quality-adjusted life-years (QALYs) using the International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life. The incremental cost-effectiveness ratio (ICER) between the groups was our primary outcome. Sensitivity analyses were performed.RESULTS:
The mean age was 58.3 (SD = 9.6) years. Annual overall costs were 738.42 in the treatment group and 605.82 in the control group; annual QALY gains were 0.0152 and 0.0037 respectively. The base case ICER was 11,770.52; ICERs in the sensitivity analyses ranged from -9,303.78 to 22,307.67.CONCLUSIONS:
The app Tät II is a cost-effective treatment method for women with MUI and UUI.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Incontinência Urinária
/
Incontinência Urinária por Estresse
/
Aplicativos Móveis
Tipo de estudo:
Clinical_trials
/
Health_economic_evaluation
Limite:
Adolescent
/
Adult
/
Female
/
Humans
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article